- Iona Heath, general practitioner (iona.heath@dsl.pipex.com)1
- 1Caversham Group Practice, London NW5 2UP
- Accepted 2 February 2005
Shifting drug spending from the worried well in developed countries to those with treatable disease in poorer nations will benefit the health of everyone
Introduction
Investment in health care, especially when it is driven by the interests of pharmaceutical companies, seems to produce a J curve. For most of the curve, the more money spent, the better the health outcomes, but after a certain point, the more spending and the more emphasis on health at the expense of other areas of human activity and achievement, the worse overall health becomes. Many poorer countries are trapped high on the long arm of the curve while richer countries seem intent on exploring the upper end of the short arm through the excessive self confidence of preventive medicine.1 The emphasis on preventive care damages patients in rich countries by tipping them towards misery. This process is built on a foundation of fear and is fanned by economic and political pressures.

A fraction of the spending on preventive medicine in rich countries could make a huge difference to the health of poorer nations
Health and wealth
Amartya Sen has compared people living in Bihar, Kerala, and the United States.2 Bihar is the poorest state in India, and Kerala is the state that has invested most heavily in education and achieved the highest rates of literacy. Predictably, life expectancy is lowest in Bihar and highest in the United States, with Kerala's falling between the two but much closer to the United States. However, the rates of self reported illness are paradoxical: low in Bihar, where the low expectations of health are disturbing, and enormously high in the United States, which is equally disturbing but for different reasons. Kerala combines the greatest longevity and the highest rate of self reported illness of all the Indian states. It seems …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012